Ogawa Ryo, Nakashima Ichiro
Department of Neurology, Tohoku Medical and Pharmaceutical University.
Brain Nerve. 2022 Jul;74(7):899-904. doi: 10.11477/mf.1416202145.
More than 2 years have passed since the outbreak of coronavirus disease 2019 (COVID-19), but there is still no sign that the COVID-19 pandemic has ended. Although vaccines have shown high efficacy against severe acute respiratory syndrome coronavirus 2, a risk of adverse reactions and thrombosis has also been reported. Here we review the current knowledge regarding vaccination in patients with neuroimmunological diseases and those receiving immunosuppressive drugs or disease-modifying therapy.
自2019冠状病毒病（COVID-19）爆发以来，已经过去了两年多，但仍没有迹象表明COVID-19大流行已经结束。尽管疫苗已显示出对严重急性呼吸综合征冠状病毒2的高效性，但也有不良反应和血栓形成的风险报道。在此，我们综述了有关神经免疫疾病患者以及接受免疫抑制药物或疾病修饰治疗的患者接种疫苗的现有知识。
